GSK · 10000+ people · Public
Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology
- Baar Onyx
- Hybrid
- US$204,000 – US$340,000 pa
- Director
Leads the design and execution of real-world evidence and health outcomes studies for oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing. Requires deep knowledge of RWD sources and payer evidence needs.